Overview
What is Cellmates On The Run Foundation?
The Cellmates On The Run Foundation, doing business as the Chicago Diabetes Project, is a nonprofit organization based in Chicago, Illinois. Their primary mission is to support a global collaboration of research scientists in an attempt to functionally cure diabetes. They aim to achieve this by pursuing three goals: obtaining FDA approval for islet cell transplantation with systemic immunosuppression to treat brittle type I diabetic patients, developing a method to safely encapsulate islets to eliminate the need for long-term immunosuppression, and creating technology to reproduce human islets for an unlimited source of glucose-responsive insulin-secreting cells. Additionally, the foundation raises awareness of type I diabetes through events and helps fund the purchase of research equipment. With a team of five dedicated individuals, the Cellmates On The Run Foundation is committed to advancing diabetes research and treatment.
Official website here: www.chicagodiabetesproject.org/
Is Cellmates On The Run Foundation legitimate?
Cellmates On The Run Foundation is a legitimate nonprofit organization registered as a 501(c)(3) entity. Cellmates On The Run Foundation submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $71,797
For more financial information, click here
What is the mission statement of Cellmates On The Run Foundation?
The Cellmates On The Run Foundation's mission is focused on supporting a global collaboration of research scientists in their pursuit to functionally cure diabetes. They aim to achieve this by facilitating the work of researchers and physicians, specifically through islet cell transplantation. The foundation has set three primary goals: first, to secure FDA approval for islet cell transplantation in conjunction with systemic immunosuppression for the treatment of brittle type I diabetes patients. Second, they aim to develop a safe method for encapsulating islets, thereby eliminating the need for long-term immunosuppression. Lastly, they strive to advance technology to reproduce human islets, creating an endless supply of glucose-responsive insulin-secreting cells. In addition to supporting research, the foundation also raises awareness about type I diabetes through various events and assists in the procurement of necessary research equipment.
Official website here: www.chicagodiabetesproject.org/
Who is the CEO of Cellmates On The Run Foundation?
Jill Dine is the Executive Director of Cellmates On The Run Foundation.
Official website here: www.chicagodiabetesproject.org/
What is the revenue of Cellmates On The Run Foundation?
Cellmates On The Run Foundation's revenue in 2022 was $1,249,704.
Official website here: www.chicagodiabetesproject.org/
Who are the executives of Cellmates On The Run Foundation and what are their salaries?
The average compensation at Cellmates On The Run Foundation during 2022 was $14,359. There are 5 employees at Cellmates On The Run Foundation.
Here are 5 key members and their salaries:
- Jill Dine (Executive Director)
- Amy Cogswell (Director)
- John Dine (Director)
- Brigitte Oberholzer (Director)
- Jennifer Cook (Director - Treasurer)
Official website here: www.chicagodiabetesproject.org/
Where can I find the form 990 for Cellmates On The Run Foundation?
The Cellmates On The Run Foundation’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.chicagodiabetesproject.org/
Learn more at the official website: www.chicagodiabetesproject.org/
Mission Statement of Cellmates On The Run Foundation
The Cellmates On The Run Foundation is dedicated to supporting a global collaboration of research scientists in their mission to functionally cure diabetes. This nonprofit organization aims to achieve this goal by providing support to researchers and physicians, focusing on islet cell transplantation as a potential solution. The Foundation has set three primary objectives. Firstly, it seeks to secure FDA approval for islet cell transplantation in conjunction with systemic immunosuppression, targeting brittle type I diabetic patients. Secondly, the Foundation works towards developing a safe method for encapsulating islets, eliminating the need for long-term immunosuppression. Lastly, it strives to advance technology that can reproduce human islets, ensuring an unlimited supply of glucose-responsive insulin-secreting cells. In addition to its research efforts, the Cellmates On The Run Foundation raises awareness about type I diabetes through various events and helps procure necessary research equipment.
Impact
This information is meant to be a general summary of Cellmates On The Run Foundation. Please take the time to review official sources before making any decisions based upon the content provided here.
Saturday, July 20, 2024
Cellmates On The Run Foundation is making a significant impact in the field of medical research by supporting a global collaboration of research scientists in their efforts to functionally cure diabetes. The foundation specifically focuses on supporting research scientists and physicians working on islet cell transplantation to find innovative solutions for treating diabetes. Their goals include seeking FDA approval for islet cell transplantation with systemic immunosuppression, developing a method to safely encapsulate islets without the need for long-term immunosuppression, and creating technology to produce an unlimited source of glucose-responsive insulin-secreting cells.
Through their work, Cellmates On The Run Foundation aims to contribute to the fight against type I diabetes, raise awareness about the disease through events, and assist in the purchase of research equipment. Their dedication to supporting this important cause underscores their commitment to advancing medical research and ultimately finding a functional cure for diabetes.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Organization Details
Founding Year
2016
Principal Officer
Jill Dine
Main Address
1074 W TAYLOR STREET STE 233, CHICAGO, IL, 60607
NTEE Category
Code: H12 - Medical research
If you are a representative of Cellmates On The Run Foundation and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.